I am a molecular biologist and clinician-scientist focused on how dysregulated cell signaling and mechanotransduction drive cancer progression. My work integrates advanced imaging, quantitative biology, and computational approaches to uncover the molecular rules governing cell behavior, transformation, and therapeutic response.
I am committed to building interdisciplinary collaborations that bridge molecular biology, engineering, and clinical research to accelerate discovery and develop precision treatments. My long-term goal is to translate fundamental insights in cell signaling and nuclear morphology into early-detection strategies and targeted therapies that improve patient outcomes.
